Exposure to Adolescent Community Reinforcement Approach treatment procedures as a mediator of the relationship between adolescent substance abuse treatment retention and outcome.
Data from 399 adolescents, who participated in one of four randomly controlled trials of the Adolescent Community Reinforcement Approach (A-CRA) intervention, were used to examine the extent to which exposure to A-CRA procedures mediated the relationship between treatment retention and outcomes. Although zero-order correlations indicated that retention in treatment was a significant predictor of alcohol and other drug (AOD) use (r = -0.18, p < .001), this relationship was reduced to nonsignificance (p = .39) when exposure to A-CRA procedures was included in the model. Overall, the final model evidenced a very good fit (root mean square error of approximation = .00; comparative fit index = 1.00) and explained 29% and 43% of the variance in adolescents' posttreatment AOD use and AOD-related problems, respectively. In addition, Chi-Squared Automatic Interaction Detection analysis was used to derive a target level of A-CRA exposure, which was found to be significantly related to being in recovery at follow-up. The current findings are useful, as little research to date has identified significant mediators of the relationship between retention and treatment outcomes or identified target thresholds of treatment exposure.
Garner
Bryan R
BR
Chestnut Health Systems, Bloomington, IL 61701, USA. brgarner@chestnut.org
Godley
Susan H
SH
Funk
Rodney R
RR
Dennis
Michael L
ML
Smith
Jane Ellen
JE
Godley
Mark D
MD
D000293:Adolescent; D000437:Alcoholism / Q000523:psychology / Q000534:rehabilitation; D002648:Child; D003153:Community Health Services; D005260:Female; D006801:Humans; D008297:Male; D008960:Models, Psychological; D010352:Patient Dropouts; D011153:Population; D011569:Psychiatric Status Rating Scales; D012959:Socioeconomic Factors; D016320:Substance Abuse Treatment Centers; D019966:Substance-Related Disorders / Q000523:psychology / Q000534:rehabilitation*; D016896:Treatment Outcome